Study guide
12.2 Hypovolemic, Cardiogenic & Anaphylactic Shock in Children
Neonatal Pediatric Transport C-NPT
Track your progress as you read
Finished sections get a check mark.
1 Introduction: The C-NPT Exam
About the C-NPT Exam: 2026 Format, Eligibility & Content Outline
2 Chapter 1: Transport Systems, Regulatory Framework & Legal Issues
1.1 Transport System Architecture, Accreditation (CAMTS) & Dispatch Triage 1.2 Regulatory & Legal Mandates: EMTALA, HIPAA, Consent & Documentation 1.3 Medical Direction, Scope of Practice & Ethical Considerations
3 Chapter 2: Safety, Communication, Crew Resource Management & Transport Environment
2.1 Crew Resource Management (CRM), Situational Awareness & Sterile Cockpit 2.2 Aircraft & Ground Ambulance Operations, Landing Zones & Vehicle Dynamics 2.3 Environmental Hazards, Weather Minimums & In-Flight Emergency Procedures 2.4 Communication in Transport: Peer Handoffs, Age-Appropriate Care, Families & Crew Stressors 2.5 Infection Control, PPE, Scene Safety & Disaster/Evacuation Planning
4 Chapter 3: Flight Physiology & Environmental Stressors
3.1 Physical Gas Laws & Transport Implications (Boyle, Dalton, Charles, Henry, Graham) 3.2 Altitude Hypoxia, Barometric Pressure Changes & Dysbarism 3.3 Acceleration Forces (G-forces), Vibration & Acoustic Stress in Transit 3.4 Thermoregulation Physics & Neutral Thermal Environment in Transit
5 Chapter 4: Invasive Procedures & Transport Monitoring
4.1 Advanced Airway Management & Endotracheal Intubation in Transit 4.2 Pleural Decompression (Needle Thoracostomy & Chest Tube Management) 4.3 Vascular Access: Umbilical Lines (UAC/UVC), Intraosseous (IO) & Arterial Lines
6 Chapter 5: Transport Equipment, Respiratory Physiology & Mechanical Ventilation
5.1 Transport Incubators (Isolettes), Thermal Control & Electrical/Gas Power Systems 5.2 Portable Ventilators & Modes (PC, VC, PRVC, High Frequency) 5.3 Gas Cylinder Duration Calculations, Oxygen Delivery & Inhaled Nitric Oxide (iNO) 5.4 Respiratory Physiology: Acid-Base Balance, Oxygenation, Lung Mechanics & Troubleshooting
7 Chapter 6: Transport Pharmacology, Resuscitation, Fluids & Electrolytes
6.1 Vasoactive Infusions & Inotropes (Epinephrine, Dopamine, Dobutamine, Milrinone) 6.2 Sedation, Analgesia & Neuromuscular Blockade in Transport 6.3 Prostaglandin E1 (Alprostadil) & Surfactant Replacement Therapy 6.4 Resuscitation Protocols (NRP, PALS) & Shock Fluid Resuscitation 6.5 Antimicrobial Pharmacology in Neonatal & Pediatric Transport 6.6 Post-Resuscitation Care, Defibrillation & Cardioversion in Transit, ECMO Indications & the Transport-vs-Stay Decision 6.7 Fluid & Electrolyte Therapy Across the Ages: Maintenance, Dehydration, Fluid Overload & Electrolyte Emergencies
8 Chapter 7: Neonatal Respiratory Pathologies & Management
7.1 Respiratory Distress Syndrome (RDS) & Surfactant Deficiency 7.2 Meconium Aspiration Syndrome (MAS) & Persistent Pulmonary Hypertension (PPHN) 7.3 Transient Tachypnea (TTN), Neonatal Pneumothorax & Congenital Diaphragmatic Hernia (CDH) 7.4 Neonatal Upper Airway Anomalies, Aspiration, Pneumonia, Chronic Lung Disease & Respiratory Failure
9 Chapter 8: Neonatal Cardiovascular Critical Care
8.1 Ductal-Dependent Cyanotic Congenital Heart Defects (TGA, TOF, Tricuspid Atresia) 8.2 Ductal-Dependent Systemic Blood Flow Lesions (HLHS, Coarctation, Interrupted Arch) 8.3 Neonatal Arrhythmias, Cardiogenic Shock & Post-Resuscitation Care 8.4 Acyanotic Congenital Heart Lesions, Patent Ductus Arteriosus, Obstructed TAPVR & Neonatal Heart Failure
10 Chapter 9: Neonatal Neurological & Metabolic Crises
9.1 Hypoxic-Ischemic Encephalopathy (HIE) & Passive/Active Therapeutic Hypothermia 9.2 Neonatal Seizures & Intraventricular Hemorrhage (IVH) 9.3 Neonatal Hypoglycemia, Electrolyte Derangements & Hyperbilirubinemia 9.4 Subgaleal Hemorrhage, Neonatal Sepsis & Meningitis, and Perinatal Substance Exposure (NOWS)
11 Chapter 10: Neonatal Surgical Emergencies, Neural Tube Defects & ELBW Care
10.1 Abdominal Wall Defects (Gastroschisis vs. Omphalocele) & TEF/Esophageal Atresia 10.2 Necrotizing Enterocolitis (NEC), Malrotation with Volvulus & Intestinal Obstruction 10.3 Care of the Extremely Low Birth Weight (ELBW) Infant (<1000g) in Transit 10.4 Neural Tube Defects: Myelomeningocele, Encephalocele & Transport of the Newborn With an Open Spinal Defect
12 Chapter 11: Pediatric Respiratory Emergencies
11.1 Acute Upper Airway Obstruction (Croup, Epiglottitis, Bacterial Tracheitis, Foreign Body) 11.2 Lower Airway Crises: Status Asthmaticus & Severe Bronchiolitis 11.3 Pediatric Acute Respiratory Distress Syndrome (PARDS) & Severe Pneumonia
13 Chapter 12: Pediatric Shock & Cardiovascular Crises
12.1 Pathophysiology & Transport Management of Pediatric Septic Shock 12.2 Hypovolemic, Cardiogenic & Anaphylactic Shock in Children 12.3 Pediatric Cardiac Emergencies: SVT, Ventricular Arrhythmias & Myocarditis 12.4 Pediatric Cardiovascular Crises: Palliated Congenital Heart Disease, Pulmonary Hypertensive Crisis, Pericarditis & Tamponade, Hypertensive Emergency & Anterior Mediastinal Mass
14 Chapter 13: Pediatric Neurological Emergencies & Trauma
13.1 Status Epilepticus, Altered Mental Status & Meningitis/Encephalitis 13.2 Pediatric Traumatic Brain Injury (TBI) & Increased Intracranial Pressure (ICP) 13.3 Blunt/Penetrating Trauma, Spinal Motion Restriction & Thermal Burns 13.4 Non-Accidental Trauma, Smoke Inhalation (Carbon Monoxide & Cyanide) & Heat Illness
15 Chapter 14: Pediatric Toxicological, Environmental & Endocrine Emergencies
14.1 Common Pediatric Toxic Ingestions, Poisonings & Antidotes 14.2 Diabetic Ketoacidosis (DKA) & Environmental Emergencies (Submersion, Hypothermia) 14.3 Button Battery & Foreign-Body Ingestions, Bites & Envenomations, and Hazardous-Material Exposures
16 Chapter 15: Pediatric Metabolic & Hematologic Emergencies
15.1 Anemia, Sickle Cell Disease, Coagulopathies & Blood Product Administration 15.2 Oncologic Emergencies, Acute Kidney Injury & Pediatric Electrolyte Crises
12.2 Hypovolemic, Cardiogenic & Anaphylactic Shock in Children
Key Takeaways Explain This Topic AI
Hypovolemic shock is the most common form of pediatric shock worldwide, characterized by reduced preload, contracted end-diastolic volume, and compensatory tachycardia; clinical dehydration is categorized into mild (3–5%), moderate (6–9%), and severe (≥10%), managed with 20 mL/kg isotonic crystalloid boluses.
In pediatric hemorrhagic shock, clear crystalloid boluses should be restricted to 20–40 mL/kg to prevent hemodilution, hypothermia, and trauma-induced coagulopathy, transitioning early to a 1:1:1 balanced massive transfusion protocol (PRBCs, FFP, platelets) alongside Tranexamic Acid (TXA, 15–20 mg/kg within 3 hours).
Cardiogenic shock is defined by primary pump failure with high preload, presenting with hepatomegaly, jugular venous distension, gallop rhythm (S3/S4), and pulmonary crackles; standard fluid boluses can trigger catastrophic pulmonary edema, requiring cautious 5–10 mL/kg fluid challenges over 10–20 minutes and early inodilator/inotrope therapy (Milrinone 0.25–0.75 mcg/kg/min or Dobutamine).
Anaphylactic shock is an acute IgE-mediated type I hypersensitivity crisis causing massive distributive vasodilation and bronchospasm; intramuscular Epinephrine (0.01 mg/kg of 1:1,000 [1 mg/mL], max single dose 0.3 mg in prepubertal children, 0.5 mg in adolescents) injected into the anterolateral thigh is the undisputed first-line therapy, repeatable every 5–15 minutes.
Profound distributive plasma leakage in anaphylaxis (up to 35% of intravascular volume within minutes) mandates aggressive 20 mL/kg crystalloid boluses, continuous IV Epinephrine infusion for refractory shock, and proactive early airway management before laryngeal angioedema obstructs visualization.
Last updated: September 2026
Hypovolemic, Cardiogenic & Anaphylactic Shock in Children
Circulatory shock in pediatric patients stems from diverse pathophysiological mechanisms requiring vastly different transport resuscitation strategies. While hypovolemic shock demands rapid volume expansion, cardiogenic shock can be dramatically exacerbated by fluid boluses, and anaphylactic shock requires immediate intramuscular catecholamines to arrest immune mast cell degranulation. Critical care transport clinicians must possess the diagnostic precision to differentiate these shock states rapidly at the bedside and initiate targeted, organ-sparing therapies.
Hypovolemic Shock: Dehydration vs Hemorrhage
Hypovolemic shock is the most prevalent etiology of shock in children worldwide. The fundamental physiological defect is an absolute deficiency of intravascular blood volume , which leads to decreased venous return (preload) to the right atrium, reduced ventricular end-diastolic volume, diminished stroke volume, and a secondary drop in cardiac output ( C O = H R × S V CO = HR \times SV CO = H R × S V ).
Clinical Grading of Non-Hemorrhagic Dehydration
In gastroenteritis, diabetic ketoacidosis, or environmental heat illness, fluid loss depletes extracellular fluid compartments. Clinicians assess severity by calculating estimated percentage of body weight loss:
Mild Dehydration (3%–5% in infants, 3%–4% in older children):
Physical findings: Alert mental status, slightly dry buccal mucosa, normal fontanelle, normal heart rate, normal blood pressure, capillary refill < 2 seconds <2\text{ seconds} < 2 seconds , and normal or mildly decreased urine output.
Moderate Dehydration (6%–9% in infants, 6%–8% in older children):
Physical findings: Sunken anterior fontanelle, slightly sunken orbits, dry mucous membranes, marked resting tachycardia, decreased skin turgor (delayed skin pinch recoil), oliguria ( < 1 mL/kg/hr <1\text{ mL/kg/hr} < 1 mL/kg/hr ), cool extremities, and prolonged capillary refill (2 to 3 seconds).
Severe Dehydration ( ≥ 10 % \ge 10\% ≥ 10% in infants, ≥ 9 % \ge 9\% ≥ 9% in older children):
Physical findings: Deeply sunken fontanelle and orbits, dry parchment-like mucosa, absence of tears, profound lethargy or stupor, marked tachycardia with thready pulses, delayed capillary refill ( > 3 − 4 seconds >3-4\text{ seconds} > 3 − 4 seconds ), cool and mottled extremities, anuria, and progression to hypotension (decompensated shock).
Resuscitation Protocol for Dehydration
Emergent Volume Expansion: Administer 20 mL/kg of isotonic balanced crystalloid (Plasma-Lyte or Lactated Ringer's) via rapid push over 10 to 20 minutes. If shock signs persist, repeat 20 mL/kg boluses up to 40 to 60 mL/kg, reassessing heart rate, pulse quality, and capillary refill after each aliquot.
Deficit & Maintenance Calculation: Once systemic perfusion is restored, transition to continuous IV infusion. Calculate 24-hour maintenance fluids using the Holliday-Segar method :
- 100 mL/kg 100\text{ mL/kg} 100 mL/kg for the first 10 kg of body weight
- 50 mL/kg 50\text{ mL/kg} 50 mL/kg for the next 10 kg (11–20 kg)
- 20 mL/kg 20\text{ mL/kg} 20 mL/kg for each additional kg above 20 kg
Add remaining deficit fluid (calculated as % dehydration × weight (kg) × 10 mL \%\text{ dehydration} \times \text{weight (kg)} \times 10\text{ mL} % dehydration × weight (kg) × 10 mL ), replacing half over the first 8 hours and the remainder over the subsequent 16 hours.
Hemorrhagic Shock in Pediatric Trauma
Pediatric circulating blood volume averages 70 to 80 mL/kg . Consequently, acute loss of relatively small absolute blood volumes (e.g., 150 mL in an infant) represents massive hemorrhage (>20% blood volume):
Class I Hemorrhage (<15% blood loss): Normal vital signs, mild anxiety.
Class II Hemorrhage (15%–30% blood loss): Tachycardia, tachypnea, narrowed pulse pressure, delayed capillary refill, normal systolic blood pressure (compensated shock).
Class III Hemorrhage (30%–40% blood loss): Marked tachycardia, tachypnea, oliguria, altered mental status, and hypotension (decompensated shock).
Class IV Hemorrhage (>40% blood loss): Profound hypotension, barely palpable central pulses, obtundation, anuria, and imminent cardiac arrest.
Damage Control Resuscitation & Massive Transfusion Protocol
Crystalloid Restriction: Clear crystalloid resuscitation in hemorrhagic trauma must be strictly limited to 20 to 40 mL/kg maximum . Infusing large volumes of crystalloid causes hemodilution of clotting factors and platelets, lowers core body temperature (inducing hypothermia), disrupts endothelial integrity, and dislodges early hemostatic clots ("popping the clot").
Balanced Massive Transfusion (1:1:1 Ratio): If hypotension persists after an initial 20 mL/kg crystalloid bolus, or immediately in catastrophic hemorrhage, initiate balanced blood product resuscitation. Transfuse uncrossed Type O-negative (or type-specific) Packed Red Blood Cells (PRBCs), Fresh Frozen Plasma (FFP), and Platelets in a 1:1:1 ratio (pediatric protocols use balanced ratios, commonly between 1:1:1 and 2:1:1) (administering aliquots of 10 to 15 mL/kg each).
Tranexamic Acid (TXA): Administer TXA—a synthetic lysine analogue that competitively inhibits plasminogen activation to prevent hyperfibrinolysis—to all pediatric trauma patients with severe hemorrhagic shock within 3 hours of injury:
Loading dose: 15 to 20 mg/kg IV (maximum 1,000 mg) infused over 10 minutes.
Maintenance infusion: 2 to 5 mg/kg/hr IV infused over the subsequent 8 hours.
Cardiogenic Shock: Recognition, Pathophysiology & Management
Cardiogenic shock is characterized by primary intrinsic myocardial pump failure , resulting in inadequate cardiac output and cellular hypoperfusion despite normal or elevated intravascular volume (elevated preload).
- Underlying Etiologies
- Acute viral myocarditis (Coxsackievirus B, Enterovirus, Adenovirus, Parvovirus B19)
- Dilated or hypertrophic cardiomyopathy
- Congenital heart disease (post-operative repair, critical aortic stenosis, ALCAPA)
- Severe prolonged dysrhythmias (sustained SVT or complete heart block)
- Severe myocardial contusion following blunt chest trauma
- Pathophysiology & The "Fluid Trap"
In cardiogenic shock, depressed myocardial contractility prevents effective ventricular emptying. End-systolic and end-diastolic ventricular volumes rise dramatically, generating dangerously elevated ventricular filling pressures. These elevated pressures transmit backward into the pulmonary veins and right atrium, creating pulmonary capillary hypertension (pulmonary edema) and systemic venous congestion (hepatomegaly and jugular venous distension).
CRITICAL TRANSPORT HAZARD: The Fluid Trap in Cardiogenic Shock
In hypovolemic shock, volume expansion restores preload and cardiac output. In cardiogenic shock, however, the failing ventricle is already functioning at or beyond the peak of the Frank-Starling curve.
Administering a standard 20 mL/kg 20\text{ mL/kg} 20 mL/kg fluid bolus to a child with cardiogenic shock precipitously elevates pulmonary capillary wedge pressure above oncotic pressure, triggering acute alveolar pulmonary edema, severe hypoxemic respiratory failure, and rapid cardiovascular collapse .
Differentiating Clinical Profile
Hepatomegaly: A firm, tender liver edge displaced > 2 to 4 cm >2\text{ to }4\text{ cm} > 2 to 4 cm below the right costal margin.
Auscultation: S3 or S4 gallop rhythm, holosystolic regurgitant murmurs, and bilateral pulmonary crackles (rales).
Respiratory: Tachypnea, grunting, intercostal retractions, and orthopnea.
Radiograph: Cardiomegaly (cardiothoracic ratio > 0.55 >0.55 > 0.55 ) and prominent pulmonary vascular congestion ("bat-wing" appearance).
Transport Management Protocol
Cautious Fluid Challenge: If intravascular volume status is uncertain, administer a test challenge of only 5 to 10 mL/kg of balanced crystalloid over 10 to 20 minutes (PALS), maintaining continuous auscultation of breath sounds and liver palpation. Abort immediately if respiratory status deteriorates or the liver edge descends.
Inotropic & Lusitropic Support:
Milrinone: A phosphodiesterase-3 (PDE-3) inhibitor that prevents degradation of intracellular cAMP in cardiomyocytes and vascular smooth muscle. It provides potent inotropy (contractility) and lusitropy (diastolic relaxation) while reducing systemic and pulmonary vascular resistance (afterload reduction). Initiate at 0.25 to 0.75 mcg/kg/min . Avoid IV bolus loading during transport to prevent sudden profound hypotension.
Dobutamine: Synthetic catecholamine with strong β 1 \beta_1 β 1 -adrenergic inotropic activity and mild β 2 \beta_2 β 2 vasodilation. Infuse at 2 to 10 mcg/kg/min .
Low-Dose Epinephrine: (0.02 to 0.05 mcg/kg/min) indicated if cardiogenic shock is accompanied by severe hypotension refractory to milrinone, maintaining coronary perfusion.
Anaphylactic Shock: Pathophysiology & Transport Resuscitation
Anaphylactic shock is an acute, life-threatening Type I IgE-mediated hypersensitivity reaction triggered by exposure to foreign antigens, such as foods (peanuts, tree nuts, cow's milk), insect venoms (Hymenoptera stings), medications (antibiotics, muscle relaxants), or natural rubber latex. Allergen Exposure
- │
- ▼
- Cross-linking of Specific IgE on Mast Cells & Basophils
- │
- ▼
- Explosive Degranulation & Mediator Release (Histamine, Tryptase, Leukotrienes)
- │
- ┌────┴──────────────────────────────┬──────────────────────────────┐
- ▼ ▼ ▼
- Massive Distributive Vasodilation Endothelial Hyperpermeability Bronchoconstriction & Angioedema
- │ │ │
- Profound Drop in SVR Extravasation of 35% Blood Vol Laryngeal Edema & Stridor
- Severe Arterial Hypotension Severe Distributive Hypovolemia Severe Intractable Wheezing
- Degranulation Cascade & Multi-System Collapse
When an allergen cross-links antigen-specific IgE bound to high-affinity F c ϵ R I Fc\epsilon RI F cϵ R I receptors on tissue mast cells and circulating basophils, explosive degranulation occurs. This releases preformed mediators (histamine, tryptase, chymase) and stimulates rapid de novo synthesis of leukotrienes ( L T C 4 , L T D 4 , L T E 4 LTC_4, LTD_4, LTE_4 L T C 4 , L T D 4 , L T E 4 ), prostaglandin D 2 D_2 D 2 , and platelet-activating factor:
Cardiovascular Collapse: Histamine stimulates vascular H 1 H_1 H 1 and H 2 H_2 H 2 receptors, triggering nitric oxide release that induces massive systemic arterial vasodilation. Simultaneously, severe endothelial hyperpermeability allows up to 35% of intravascular blood volume to extravasate into extravascular tissues within 10 minutes , generating profound combined distributive and hypovolemic shock.
Airway & Respiratory Failure: Leukotrienes and histamine stimulate bronchial smooth muscle contraction, inducing severe bronchospasm, mucous plugging, and lower airway wheezing. Mucosal edema of the pharynx, larynx, and vocal cords causes acute upper airway obstruction manifested by stridor, hoarseness, and asphyxiation.
Cutaneous & Gastrointestinal Signs: Diffuse urticaria, intense pruritus, periorbital/lip angioedema, nausea, colicky abdominal cramping, vomiting, and diarrhea.
Transport Resuscitation Protocol for Anaphylaxis
First-Line Drug — Intramuscular Epinephrine:
Formulation: 1:1,000 concentration ( 1 mg/mL 1\text{ mg/mL} 1 mg/mL ).
Dosing: 0.01 mg/kg ( 0.01 mL/kg 0.01\text{ mL/kg} 0.01 mL/kg of 1:1,000). Maximum single dose is 0.3 mg in prepubertal children and 0.5 mg in adolescents .
Anatomical Site: Administer intramuscularly into the mid-anterolateral thigh (vastus lateralis) . The superior vascularity of the vastus lateralis achieves peak plasma epinephrine concentrations within 8 minutes—significantly faster and higher than deltoid or subcutaneous routes.
Frequency: Repeat every 5 to 15 minutes as clinically indicated for persistent symptoms or refractory hypotension.
Aggressive Volume Expansion: Rapidly infuse 20 mL/kg balanced crystalloid boluses under pressure to replace massive third-space extravasation and fill the dilated vascular bed. Repeat as needed up to 40 to 60 mL/kg.
Continuous Epinephrine Infusion for Refractory Anaphylaxis: If shock or bronchospasm persists despite repeated IM injections and fluid boluses, initiate continuous intravenous Epinephrine at 0.05 to 0.3 mcg/kg/min titrated to blood pressure and respiratory ease.
Second-Line Adjunctive Medications (Never Delay or Substitute for Epinephrine):
H 1 H_1 H 1 -Antihistamine: Diphenhydramine 1 mg/kg 1\text{ mg/kg} 1 mg/kg IV/IM (max 50 mg) for urticaria and pruritus relief.
H 2 H_2 H 2 -Antihistamine: Famotidine 0.25 to 0.5 mg/kg 0.25\text{ to }0.5\text{ mg/kg} 0.25 to 0.5 mg/kg IV (max 20 mg) to block cardiac histamine receptors.
Systemic Corticosteroids: Methylprednisolone 1 to 2 mg/kg 1\text{ to }2\text{ mg/kg} 1 to 2 mg/kg IV (max 60–125 mg) or Dexamethasone 0.3 to 0.6 mg/kg 0.3\text{ to }0.6\text{ mg/kg} 0.3 to 0.6 mg/kg IV. Corticosteroids take hours to act. They are often given, but evidence that they prevent biphasic reactions (recurrence after apparent resolution, reported in roughly 5% of cases and usually within about 12 hours) is weak.
Nebulized Bronchodilators: Albuterol ( 2.5 to 5 mg 2.5\text{ to }5\text{ mg} 2.5 to 5 mg ) and Ipratropium for refractory bronchospasm.
Proactive Airway Management: If stridor, severe lingual swelling, or voice alteration develops, perform early endotracheal intubation before progressive angioedema obliterates the glottic opening. Prepare an endotracheal tube 0.5 to 1.0 mm 0.5\text{ to }1.0\text{ mm} 0.5 to 1.0 mm smaller than calculated for age, have video laryngoscopy ready, and prepare a needle cricothyrotomy setup at the bedside.
Comparison Table: Differentiating Pediatric Shock Types
Clinical Parameter Hypovolemic (Dehydration) Hemorrhagic (Trauma) Cardiogenic (Pump Failure) Anaphylactic (Distributive)
Primary Pathology Extracellular water/solute loss Acute whole blood loss Myocardial pump dysfunction Mast cell degranulation & vasodilation
Preload (Filling Pressure) Markedly Decreased Markedly Decreased Markedly Elevated Decreased (relative & third-space)
Contractility Normal to Hyperdynamic Normal to Hyperdynamic Severely Depressed Normal to Hyperdynamic
Systemic Vascular Resistance High (Vasoconstriction) High (Vasoconstriction) High (Vasoconstriction) Severely Low (Vasodilation)
Liver Edge Normal / Not Palpable Normal / Not Palpable Enlarged ( > 2 − 4 cm >2-4\text{ cm} > 2 − 4 cm below margin) Normal
Breath Sounds Clear bilaterally Clear (unless hemothorax) Bilateral crackles / rales / grunting Stridor & expiratory wheezing
First-Line Intervention 20 mL/kg balanced crystalloid 1:1:1 PRBCs, FFP, Platelets + TXA Milrinone or Dobutamine; fluid restriction IM Epinephrine 1:1,000 (0.01 mg/kg)
Realistic Transport Scenario: Pediatric Anaphylaxis in Transit
A transport team is dispatched to a summer camp to retrieve an 8-year-old male (weight 26 kg) who was stung by multiple yellow jackets. Within 10 minutes, the child developed generalized urticaria, facial swelling, hoarseness, and inspiratory stridor, collapsing onto the ground. On crew arrival, the patient is lethargic, displaying prominent intercostal retractions, loud stridor, and diffuse wheezing. Vital signs: heart rate 168 bpm, respiratory rate 42 breaths/min, blood pressure 72/40 mmHg (mean arterial pressure 51 mmHg; minimum acceptable systolic blood pressure is 70 + [ 2 × 8 ] = 86 mmHg 70 + [2 \times 8] = 86\text{ mmHg} 70 + [ 2 × 8 ] = 86 mmHg , confirming decompensated anaphylactic shock), and SpO2 86% on room air.
The transport nurse immediately injects 0.26 mg of Epinephrine 1:1,000 (0.26 mL) intramuscularly into the right mid-anterolateral thigh and applies 100% FiO2 via non-rebreather mask. While the flight paramedic establishes a proximal tibial IO line, 520 mL (20 mL/kg) of Plasma-Lyte is rapidly infused under pressure. Five minutes post-injection, the child remains hypotensive (BP 76/44 mmHg) with persistent inspiratory stridor. A second dose of 0.26 mg Epinephrine 1:1,000 IM is injected into the left anterolateral thigh, and a continuous IV Epinephrine infusion is initiated at 0.1 mcg/kg/min. Methylprednisolone (50 mg IV) and Famotidine (13 mg IV) are administered via the IO line.
Within 4 minutes of the second epinephrine dose, the stridor completely resolves, wheezing diminishes, heart rate slows to 124 bpm, and blood pressure rebounds to 96/58 mmHg (MAP 71 mmHg). The child becomes fully alert and speaks in full sentences, successfully averting emergency surgical airway placement during subsequent rotor transport to the pediatric trauma center.
Clinical Pearls for Pediatric Shock Forms
Important
Intramuscular Vastus Lateralis is Mandatory: In pediatric anaphylaxis, never inject epinephrine subcutaneously or into the deltoid. Absorption is erratic and delayed. The anterolateral thigh delivers immediate peak plasma concentrations within 8 minutes.
Tip
The 1:1:1 Trauma Transfusion Principle: In pediatric hemorrhagic trauma, avoid clear crystalloid overload. Transition early to balanced 1:1:1 uncrossed PRBCs, FFP, and platelets, and administer Tranexamic Acid (15–20 mg/kg) within 3 hours of injury to inhibit hyperfibrinolysis.
Note
Recognizing Cardiogenic Shock Before Bolusing: Always palpate the right upper quadrant for hepatomegaly and auscultate the lung fields for crackles before giving a fluid bolus to a child in shock. If hepatomegaly and crackles are present, withhold large volume boluses and start inotropes.